image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Scapa - Shares hit new high of 252p

June 2016

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SCPA
  • Price:
  • 246p
The shares surged to a new high of 252p after Scapa announced that trading profits and margins are running ahead of expectations for the year ended 30 March 2016.  Healthcare (advanced woundcare products and medical tapes) delivered a strong 26.4% annual revenue growth or 19% at constant exchange rates, with margins maintained year-on-year. New business was won through its focus on turnkey solutions for the leading global firms.In its legacy industrial side, which makes tapes for industrial and transport applications, trading profit and margin are ahead of last year.“Healthy” cash flow ensured it ended the year with net debt of a lower than expected £2.7m, and with a borrowing facility of £4 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X